FOX vs TRDA · P/E 13, rev $16.30B vs P/E 12, rev $210.8M
Fox Corp Class B (FOX) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the FOX and TRDA stock pages for the full models.
Not investment advice.